ARCA BIOPHARMA INC - COM (ABIO)

CUSIP: 00211Y506

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / COM
Total 13F shares
7,477,164
Share change
+219,017
Total reported value
$12,710,802
Put/Call ratio
0.47%
Price per share
$1.70
Number of holders
23
Value change
+$357,728
Number of buys
10
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 00211Y506?
CUSIP 00211Y506 identifies ABIO - ARCA BIOPHARMA INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ARCA BIOPHARMA INC - COM (ABIO) as of Q4 2023

As of 31 Dec 2023, ARCA BIOPHARMA INC - COM (ABIO) was held by 23 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,477,164 shares. The largest 10 holders included Cable Car Capital LLC, Western Standard LLC, BML Capital Management, LLC, VANGUARD GROUP INC, Newtyn Management, LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, and DIMENSIONAL FUND ADVISORS LP. This page lists 23 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.